Insulin Human C73 IgE (c73) Biomarker Testing
It measures IgE antibodies to human insulin to assess allergy risk, with convenient ordering and clear results through Vitals Vault’s Quest network.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
Insulin Human C73 IgE is an allergen-specific IgE blood test that looks for IgE antibodies directed against human insulin. In plain terms, it helps answer whether your immune system is showing an “allergy-type” response to insulin.
This test is most useful when you have symptoms that happen soon after an insulin injection or infusion, such as hives, itching, swelling, wheezing, or lightheadedness. It can also be part of a broader workup when insulin reactions are suspected but not obvious.
Because insulin reactions can range from mild skin symptoms to severe, fast-onset reactions, you should use this result as one piece of the puzzle and review it with your clinician. A lab test can support clinical decision-making, but it cannot diagnose or rule out an allergy by itself.
Do I need a Insulin Human C73 IgE test?
You may want this test if you notice allergy-like symptoms within minutes to a few hours after using insulin. Common examples include localized redness or swelling that spreads beyond the injection site, widespread hives, facial or lip swelling, coughing or wheezing, or feeling faint. If symptoms are severe or involve breathing, that is urgent medical care rather than a “wait and see” lab situation.
This test is also reasonable if you and your clinician are trying to distinguish between an insulin allergy and other common causes of injection reactions, such as irritation from adhesives (pump or CGM tape), sensitivity to preservatives in a specific insulin product, or skin inflammation from repeated injections.
If you have diabetes and you need insulin to stay safe, the goal is usually not to “prove” an allergy and stop insulin on your own. The goal is to clarify risk so your clinician can choose safer options, such as switching formulations, adjusting delivery method, adding an allergy plan, or coordinating allergy/immunology evaluation when needed.
This is a laboratory-developed allergen-specific IgE assay performed in a CLIA-certified lab; results should be interpreted with your symptoms and clinical history, not used as a standalone diagnosis.
Lab testing
Order labs to measure Insulin, Human (c73) IgE
from $29.49 at Quest Diagnostics
About 1 week
Schedule online — results typically within a week
Clear next steps
Guidance included, with follow-up care available
HSA / FSA
Eligible for pre-tax health spending accounts
Get this test with Vitals Vault
Vitals Vault lets you order Insulin Human C73 IgE testing without a separate doctor visit, and you can complete your blood draw through the Quest network. That can be helpful when you are trying to move from “something feels off after insulin” to a documented result you can discuss with your care team.
After your results post, PocketMD can help you put the number into context, including what “sensitization” means, what follow-up questions to ask, and which related tests are commonly paired with insulin IgE when reactions are ongoing.
If your situation changes, you can also use Vitals Vault to re-order the same test for trend tracking or add companion labs to map out other contributors to symptoms (for example, general inflammation, anemia, or other allergy markers), based on what you and your clinician decide is appropriate.
- Order online and draw at a Quest location
- Clear, patient-friendly results view with context
- PocketMD support for next-step questions and retest planning
Key benefits of Insulin Human C73 IgE testing
- Helps assess whether your immune system has an IgE-type sensitization to human insulin.
- Adds objective data when you have hives, swelling, or breathing symptoms after insulin use.
- Supports safer insulin planning when you need insulin but suspect allergic reactions.
- Can help differentiate allergy-type reactions from irritation, technique issues, or adhesive sensitivity.
- Guides whether allergy/immunology referral and supervised challenge testing may be warranted.
- Helps you and your clinician decide if switching insulin formulations or delivery methods makes sense.
- Creates a baseline you can compare over time if symptoms change or treatment is adjusted.
What is Insulin Human C73 IgE?
Insulin Human C73 IgE is a blood test that measures allergen-specific immunoglobulin E (IgE) antibodies directed at human insulin. IgE is the antibody class involved in immediate-type allergic reactions, which can cause symptoms like hives (urticaria), itching, swelling (angioedema), wheezing, and in rare cases anaphylaxis.
A positive result suggests your immune system recognizes insulin as an allergen and has produced IgE that can bind to it. That is called sensitization. Sensitization increases the likelihood of an allergy-type reaction, but it does not guarantee you will react every time, and it does not measure how severe a reaction will be.
A negative result makes an IgE-mediated insulin allergy less likely, but it does not rule out other types of reactions. Some insulin-related problems are non-IgE immune reactions, delayed hypersensitivity, or local skin irritation from repeated injections, alcohol swabs, adhesives, or additives in a specific insulin product.
IgE-mediated vs non-IgE reactions
IgE-mediated reactions tend to happen quickly after exposure and can involve hives, flushing, swelling, or respiratory symptoms. Non-IgE reactions may be delayed (hours to days), more localized, or present as persistent skin inflammation. Your timing and symptom pattern matter as much as the lab value.
Why the test is labeled “c73”
“c73” is a lab coding convention used for allergen-specific IgE targets. In this case it refers to human insulin as the allergen source. Your report may show the result as a quantitative value and/or an IgE “class,” depending on the lab format.
What do my Insulin Human C73 IgE results mean?
Low (or negative) Insulin Human C73 IgE
A low or negative result generally means the test did not detect meaningful IgE antibodies to human insulin. If you have symptoms, this points you and your clinician toward other explanations, such as local irritation, sensitivity to preservatives, adhesive reactions, or a non-IgE immune response. If your symptoms are immediate and convincing, your clinician may still consider additional evaluation because no single blood test rules out allergy in every case.
In-range results
For allergen-specific IgE tests, “in-range” typically means negative or below the lab’s positivity threshold. That is often reassuring, especially if your symptoms are mild and not clearly linked to insulin timing. If you are troubleshooting injection-site issues, an in-range result can help focus attention on technique, site rotation, skin care, and the specific product or device you are using.
High (positive) Insulin Human C73 IgE
A high or positive result suggests sensitization to human insulin and increases the likelihood that your symptoms could be IgE-mediated. The most important next step is matching the result to your real-world pattern: how soon symptoms start after insulin, what symptoms occur, and whether they improve when the insulin product or delivery method changes. Because insulin is often essential therapy, do not stop or change insulin on your own; your clinician may consider switching formulations, adding pre-treatment strategies, or arranging specialist evaluation for confirmation and safety planning.
Factors that influence Insulin Human C73 IgE
Recent allergic activity and overall atopic tendency (such as eczema, asthma, or allergic rhinitis) can raise the chance of detectable IgE. The specific insulin formulation, additives, and delivery method (injections vs pump) can affect symptoms even when the IgE result is unchanged. Timing matters: if your reaction is delayed by many hours or days, IgE may not be the main mechanism. Finally, lab methods and reporting formats vary, so your clinician may interpret the value alongside other allergy testing and your history.
What’s included
- Insulin, Human (C73) Ige
Similar or related tests
Frequently Asked Questions
Do I need to fast for an Insulin Human C73 IgE test?
Fasting is not typically required for allergen-specific IgE testing. If you are combining this with other labs (like glucose or lipids), those other tests may require fasting, so follow the instructions for your full order.
What does a positive insulin IgE mean?
A positive result means your immune system has produced IgE antibodies that recognize human insulin, which is called sensitization. It supports (but does not prove) an IgE-mediated insulin allergy, so your clinician will interpret it alongside symptom timing, severity, and response to insulin changes.
Can I be allergic to insulin but have a negative IgE test?
Yes. Some reactions are not IgE-mediated, and some are due to additives, device adhesives, or skin irritation rather than insulin itself. If your symptoms are concerning, especially if they are immediate or systemic, discuss further evaluation with your clinician even if IgE is negative.
Will antihistamines affect my insulin IgE blood test?
Antihistamines generally do not change the amount of IgE measured in your blood, so they usually do not affect this test result. They can, however, reduce symptoms, which may make timing and pattern harder to observe—share your medication use with your clinician.
How soon after a reaction should I test?
You can usually test any time because IgE reflects immune sensitization rather than an immediate “flare” marker. If you are in the middle of active reactions, your clinician may also want other assessments for safety and to rule out alternative causes.
What other tests are commonly paired with insulin IgE?
Your clinician may pair this with other allergy testing (such as total IgE or other allergen-specific IgE tests) and, when appropriate, broader labs to evaluate contributors to symptoms (for example, a CBC if you have fatigue or frequent infections). The right combination depends on your symptom pattern and diabetes treatment plan.